{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:45:34Z","timestamp":1773409534075,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.dsx.2013.02.020","type":"journal-article","created":{"date-parts":[[2013,3,11]],"date-time":"2013-03-11T15:01:55Z","timestamp":1363014115000},"page":"35-37","source":"Crossref","is-referenced-by-count":8,"title":["Serum lipid peroxides and magnesium levels following three months of treatment with pioglitazone in patients with Type 2 Diabetes mellitus"],"prefix":"10.1016","volume":"7","author":[{"given":"G.","family":"Niranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mohanavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dsx.2013.02.020_bib0005","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.dsx.2013.02.020_bib0010","first-page":"147","article-title":"Type 2 Diabetes and vascular complications: a pathophysiologic view","volume":"21","author":"Khaled","year":"2010","journal-title":"Biomedical Research"},{"issue":"9","key":"10.1016\/j.dsx.2013.02.020_bib0015","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0169-409X(02)00093-5","article-title":"Troglitazone: the discovery and development of a novel therapy for the treatment of type 2 diabetes mellitus","volume":"54","author":"Parker","year":"2002","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/j.dsx.2013.02.020_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1463-1326.2002.00183.x","article-title":"Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus","volume":"4","author":"Ovalle","year":"2002","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.dsx.2013.02.020_bib0025","first-page":"683","article-title":"Management of type 2 diabetes mellitus, role of thiazolidinediones","volume":"51","author":"Jason","year":"2005","journal-title":"Canadian Family Physician"},{"key":"10.1016\/j.dsx.2013.02.020_bib0030","first-page":"58","article-title":"Peroxisome proliferator-activated receptors (PPARS): a target with a broad therapeutic potential for human diseases: an overview","volume":"2","author":"Singh","year":"2011","journal-title":"Pharmacologyonline"},{"issue":"8","key":"10.1016\/j.dsx.2013.02.020_bib0035","first-page":"1889","article-title":"Pioglitazone: beyond glucose control","volume":"160","author":"de Pablos-Velasco","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"10.1016\/j.dsx.2013.02.020_bib0040","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.2337\/diacare.21.10.1736","article-title":"Oxidative stress at onset and in early stages of type I diabetes in children and adolescents","volume":"21","author":"Dominguez","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2013.02.020_bib0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diabetes.40.4.405","article-title":"Role of oxidative stress in development of complications in diabetes","volume":"40","author":"Baynes","year":"1991","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.dsx.2013.02.020_bib0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/02656739109056444","article-title":"Oxidative stress as a precursor to the irreversible hepatocellular injury caused by hyperthermia","volume":"7","author":"Skibba","year":"1991","journal-title":"International Journal of Hyperthermia"},{"key":"10.1016\/j.dsx.2013.02.020_bib0055","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.clnu.2006.03.003","article-title":"Magnesium and diabetes mellitus: their relation","volume":"25","author":"Sales","year":"2006","journal-title":"Clinical Nutrition"},{"issue":"1","key":"10.1016\/j.dsx.2013.02.020_bib0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/diacare.27.1.134","article-title":"Magnesium intake and risk of type 2 diabetes in men and women","volume":"27","author":"Ruy","year":"2004","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.dsx.2013.02.020_bib0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archinte.1996.00440100029005","article-title":"Hypomagnesemia and diabetes mellitus. A review of clinical implications","volume":"156","author":"Tosiello","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"7","key":"10.1016\/j.dsx.2013.02.020_bib0070","first-page":"302","article-title":"Lipids in association with serum magnesium in diabetes mellitus patients","volume":"109","author":"Nasri","year":"2008","journal-title":"Bratislavske Lekarske Listy"},{"issue":"3","key":"10.1016\/j.dsx.2013.02.020_bib0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.dsx.2012.02.011","article-title":"Insulin resistance and alanine amino transaminase levels in first degree relatives of type 2 diabetes mellitus","volume":"5","author":"Kuzhandaivelu","year":"2011","journal-title":"Diabetes, Metabolic Syndrome"},{"issue":"9","key":"10.1016\/j.dsx.2013.02.020_bib0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2165\/11316510-000000000-00000","article-title":"Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US","volume":"32","author":"Tolman","year":"2009","journal-title":"Drug Safety"},{"key":"10.1016\/j.dsx.2013.02.020_bib0085","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/CIRCULATIONAHA.105.571919","article-title":"Gamma glutamyl transferase atherosclerosis and cardiovascular disease: triggering within the plaque","volume":"112","author":"Emdin","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dsx.2013.02.020_bib0090","first-page":"35","article-title":"Serum gamma glutamyl tranferase levels in obese South Indian adults with reference to atherogenic lipid risk factors and lipid peroxides","volume":"1","author":"Gopal","year":"2012","journal-title":"International Journal of Medical Science"},{"issue":"March (2)","key":"10.1016\/j.dsx.2013.02.020_bib0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1517\/14740331003623218","article-title":"Pioglitazone: side effect and safety profile","volume":"9","author":"Shah","year":"2010","journal-title":"Expert Opinion on Drug Safety"},{"issue":"2","key":"10.1016\/j.dsx.2013.02.020_bib0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/er.23.2.201","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocrine Reviews"},{"issue":"2","key":"10.1016\/j.dsx.2013.02.020_bib0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12291-009-0033-y","article-title":"Hypomagnesaemia in type 2 diabetes mellitus patients: a study on the status of oxidative and nitrosative stress","volume":"24","author":"Ankush","year":"2009","journal-title":"Indian Journal of Clinical Biochemistry"},{"issue":"6","key":"10.1016\/j.dsx.2013.02.020_bib0110","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.exger.2006.04.005","article-title":"Amelioration of age-related inflammation and oxidative stress by PPAR\u03b3 activator: Suppression of NF-\u03baB by 2,4-thiazolidinedione","volume":"41","author":"Sung","year":"2006","journal-title":"Experimental Gerontology"},{"issue":"11","key":"10.1016\/j.dsx.2013.02.020_bib0115","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.metabol.2009.05.022","article-title":"FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus","volume":"58","author":"Pavlatou","year":"2009","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"6","key":"10.1016\/j.dsx.2013.02.020_bib0120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcn020","article-title":"Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy","volume":"101","author":"Singhania","year":"2008","journal-title":"QJM"},{"issue":"22","key":"10.1016\/j.dsx.2013.02.020_bib0125","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3)","volume":"270","author":"J\u00fcrgen","year":"1995","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.dsx.2013.02.020_bib0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2007.10.057","article-title":"Selective modulation of promoter recruitment and transcriptional activity of PPAR\u03b3","volume":"364","author":"Sears","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.dsx.2013.02.020_bib0135","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1476-5381.2010.00671.x","article-title":"Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation","volume":"160","author":"Massimo","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.dsx.2013.02.020_bib0140","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/jc.2009-0911","article-title":"Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus","volume":"95","author":"Mandeep","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.dsx.2013.02.020_bib0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.beem.2007.09.004","article-title":"PPAR agonists: multimodal drugs for the treatment of type 2 diabetes","volume":"21","author":"Gross","year":"2007","journal-title":"Best Practice and Research in Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.dsx.2013.02.020_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/diaclin.23.3.115","article-title":"Elevated liver function tests in type 2 diabetes","volume":"23","author":"Elizabeth","year":"2005","journal-title":"Clinical Diabetes"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402113000210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402113000210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:59:58Z","timestamp":1539824398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402113000210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1871402113000210"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2013.02.020","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}